Zosano Pharma Corp Insider Trading for August 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Zosano Pharma Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Zosano Pharma Corp for August 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31 2016 | ZSAN | Zosano Pharma Corp | BARRETT M JAMES | 10% Owner | Sell | S | 1.01 | 50,000 | 50,440 | 2,070,276 | 2.1 M to 2.1 M (-2.36 %) |
| Aug 31 2016 | ZSAN | Zosano Pharma Corp | New Enterprise Associates 12, ... | 10% Owner | Sell | S | 1.01 | 50,000 | 50,440 | 2,070,276 | 2.1 M to 2.1 M (-2.36 %) |
| Aug 26 2016 | ZSAN | Zosano Pharma Corp | BARRETT M JAMES | 10% Owner | Sell | S | 1.21 | 1,200 | 1,452 | 2,120,276 | 2.1 M to 2.1 M (-0.06 %) |
| Aug 26 2016 | ZSAN | Zosano Pharma Corp | New Enterprise Associates 12, ... | 10% Owner | Sell | S | 1.21 | 1,200 | 1,452 | 2,120,276 | 2.1 M to 2.1 M (-0.06 %) |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | Alataris Konstantinos | President, CEO | Option Exercise | P | 1.55 | 127,389 | 197,453 | 127,389 | |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | Alataris Konstantinos | President, CEO | Option Exercise | P | 1.45 | 127,389 | 184,714 | 127,389 | |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | Alataris Konstantinos | President, CEO | Buy | P | 1.32 | 127,389 | 168,153 | 127,389 | 0 to 127.4 K |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | Lewis Hayley | VP, Reg Affairs & Q ... | Option Exercise | P | 1.55 | 4,775 | 7,401 | 4,775 | |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | Lewis Hayley | VP, Reg Affairs & Q ... | Option Exercise | P | 1.45 | 4,775 | 6,924 | 4,775 | |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | Lewis Hayley | VP, Reg Affairs & Q ... | Buy | P | 1.32 | 4,775 | 6,303 | 4,775 | 0 to 4.8 K |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | Erbez Georgia | Interim CFO | Option Exercise | P | 1.55 | 47,750 | 74,013 | 47,750 | |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | Erbez Georgia | Interim CFO | Option Exercise | P | 1.45 | 47,750 | 69,238 | 47,750 | |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | Erbez Georgia | Interim CFO | Buy | P | 1.32 | 47,750 | 63,030 | 47,750 | 0 to 47.8 K |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | WALKER JOHN PETER | Director | Option Exercise | P | 1.55 | 63,700 | 98,735 | 63,700 | |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | WALKER JOHN PETER | Director | Option Exercise | P | 1.45 | 63,700 | 92,365 | 63,700 | |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | WALKER JOHN PETER | Director | Buy | P | 1.32 | 63,700 | 84,084 | 63,700 | 0 to 63.7 K |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | KELLERMAN DONALD J | VP, Clinical Dev & ... | Option Exercise | P | 1.55 | 15,920 | 24,676 | 15,920 | |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | KELLERMAN DONALD J | VP, Clinical Dev & ... | Option Exercise | P | 1.45 | 15,920 | 23,084 | 15,920 | |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | KELLERMAN DONALD J | VP, Clinical Dev & ... | Buy | P | 1.32 | 15,920 | 21,014 | 15,920 | 0 to 15.9 K |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | P | 1.55 | 15,920 | 24,676 | 15,920 | |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | P | 1.45 | 15,920 | 23,084 | 15,920 | |
| Aug 22 2016 | ZSAN | Zosano Pharma Corp | XANTHOPOULOS KLEANTHIS G | Director | Buy | P | 1.32 | 15,920 | 21,014 | 21,920 | 6 K to 21.9 K (+265.33 %) |